Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Equillium, Inc. | Director | Director Stock Option (right to buy) | 40K | Dec 11, 2024 | Direct | ||
Checkmate Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | May 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EQ | Equillium, Inc. | Dec 11, 2024 | 1 | $0 | 4 | Dec 12, 2024 | Director |
EQ | Equillium, Inc. | Dec 11, 2024 | 0 | $0 | 3 | Dec 12, 2024 | Director |
CMPI | Checkmate Pharmaceuticals, Inc. | May 31, 2022 | 2 | $0 | 4 | May 31, 2022 | Director |
CMPI | Checkmate Pharmaceuticals, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |